NPI: 1801864145 · SAINT PETERSBURG, FL 33711 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,227 | $1.78M |
| 2019 | 23,094 | $2.75M |
| 2020 | 28,660 | $3.46M |
| 2021 | 18,724 | $1.01M |
| 2022 | 6,807 | $451K |
| 2023 | 4,717 | $304K |
| 2024 | 2,286 | $219K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 29,323 | 1,853 | $3.38M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 34,034 | 1,335 | $3.06M |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,263 | 872 | $1.28M |
| A4657 | Syringe, with or without needle, each | 3,993 | 1,310 | $804K |
| J1756 | Injection, iron sucrose, 1 mg | 7,365 | 1,233 | $586K |
| 85041 | 1,704 | 927 | $159K | |
| 85048 | 1,689 | 922 | $158K | |
| 83970 | 1,083 | 600 | $107K | |
| 83540 | 697 | 413 | $71K | |
| 83550 | 699 | 414 | $71K | |
| 82728 | 709 | 409 | $70K | |
| 82607 | 403 | 242 | $56K | |
| 82746 | 482 | 275 | $55K | |
| 82108 | 481 | 273 | $47K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 135 | 69 | $31K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 331 | 148 | $13K |
| G0008 | Administration of influenza virus vaccine | 84 | 54 | $6K |
| 90674 | 40 | 24 | $4K |